Molecular profiling of tissue samples from patients who received a Kite-manufactured gene-modified cell therapy and have developed a secondary malignancy of T-cell origin First published 13/10/2025 Last updated 05/02/2026 EU PAS number:EUPAS1000000769 Study Planned